No abstract available
Keywords:
arrhythmias; cardiac; cardiomyopathy; drug repositioning; genetics; hypertrophic; myocytes; sodium-glucose transporter 2 inhibitors.
MeSH terms
-
Arrhythmias, Cardiac* / drug therapy
-
Arrhythmias, Cardiac* / pathology
-
Benzhydryl Compounds* / pharmacology
-
Benzhydryl Compounds* / therapeutic use
-
Cardiomyopathy, Hypertrophic* / drug therapy
-
Cardiomyopathy, Hypertrophic* / genetics
-
Cardiomyopathy, Hypertrophic* / pathology
-
Glucosides* / pharmacology
-
Glucosides* / therapeutic use
-
Humans
-
Induced Pluripotent Stem Cells* / cytology
-
Induced Pluripotent Stem Cells* / metabolism
-
Sodium-Glucose Transporter 2 Inhibitors / pharmacology
-
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
Substances
-
Glucosides
-
Benzhydryl Compounds
-
empagliflozin
-
Sodium-Glucose Transporter 2 Inhibitors